Amgen | A Worldwide Pioneer in Biotechnology
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Amgen.com is the official website of Amgen Inc., a leading biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics. The site serves as a comprehensive resource for patients, healthcare professionals, and investors, offering detailed information on Amgen's products, research, and corporate responsibility initiatives.
900K
30000 / day
1.5M
50000 / day
3.8 min
4.2 pages per visit
35%
-
Domain Rating
-
Domain Authority
-
Citation Level
1980
English, etc
Website Key Features
Product Information
Detailed descriptions and prescribing information for Amgen's portfolio of medicines.
Research and Development
Insights into Amgen's innovative research and development pipeline, including clinical trials and scientific publications.
Investor Relations
Financial reports, stock information, and corporate governance details for investors and analysts.
Career Opportunities
Information on job openings, career development, and the company culture at Amgen.
Corporate Responsibility
Overview of Amgen's commitment to sustainability, ethics, and community engagement.
Patient Support
Resources and support programs for patients prescribed Amgen medications.
Healthcare Professional Resources
Educational materials and tools for healthcare providers to support patient care.
News and Media
Press releases, media contacts, and the latest news from Amgen.
Events and Presentations
Information on upcoming and past events, including webcasts and presentations.
Contact Information
Comprehensive contact details for various departments within Amgen.
Similar Sites and Competitors
Additional information
Headquarters
Amgen's global headquarters is located in Thousand Oaks, California, USA.
Global Presence
Amgen operates in over 100 countries worldwide, with a significant presence in North America, Europe, Asia, and Latin America.
Number of Employees
As of the latest data, Amgen employs approximately 22,000 people globally.
Revenue
Amgen reported a revenue of over $25 billion in the last fiscal year.
Key Products
Includes Enbrel, Neulasta, Prolia, and Xgeva among others, which are used in the treatment of various diseases including cancer, osteoporosis, and inflammatory diseases.
Awards and Recognition
Amgen has received numerous awards for its innovation, workplace environment, and corporate responsibility efforts.
Sustainability Initiatives
Amgen is committed to reducing its environmental impact through various sustainability initiatives, including energy efficiency and waste reduction programs.
HTTP headers
Security headers report is a very important part of user data protection. Learn more about http headers for amgen.com